Drug Information

Drug General Information
Drug ID
D0R3MO
Former ID
DIB019455
Drug Name
compound 35
Drug Type
Small molecular drug
Indication Discovery agent Investigative [531084]
Formula
C27H33N5O3
InChI
InChI=1S/C27H33N5O3/c1-32-9-7-18(8-10-32)17-35-26-13-19(22-15-29-30-16-22)4-6-24(26)31-27(33)25-12-21-11-23(34-2)5-3-20(21)14-28-25/h3-6,11,13,15-16,18,25,28H,7-10,12,14,17H2,1-2H3,(H,29,30)(H,31,33)/t25-/m1/s1
InChIKey
GFWDPXHTWJXOEI-RUZDIDTESA-N
PubChem Compound ID
46864283
PubChem Substance ID
99303223, 104241494, 117645895, 180417616, 249565889
Target and Pathway
Target(s) LATS2 Target Info Inhibitor [531084]
Rho associated protein kinase 2 Target Info Inhibitor [531084]
Serine/threonine kinase 38 Target Info Inhibitor [531084]
Rho-associated protein kinase 1 Target Info Inhibitor [531084]
KEGG Pathway cGMP-PKG signaling pathway
cAMP signaling pathway
Chemokine signaling pathway
Sphingolipid signaling pathway
Vascular smooth muscle contraction
Wnt signaling pathway
Axon guidance
Focal adhesion
Platelet activation
Leukocyte transendothelial migration
Regulation of actin cytoskeleton
Oxytocin signaling pathway
Pathogenic Escherichia coli infection
Shigellosis
Salmonella infection
Pathways in cancer
Proteoglycans in cancerhsa04022:cGMP-PKG signaling pathway
TGF-beta signaling pathway
Proteoglycans in cancer
MicroRNAs in cancer
PANTHER Pathway Cytoskeletal regulation by Rho GTPaseP00016:Cytoskeletal regulation by Rho GTPase
Inflammation mediated by chemokine and cytokine signaling pathway
CCKR signaling map ST
Pathway Interaction Database Coregulation of Androgen receptor activityrhoa_pathway:RhoA signaling pathway
Plasma membrane estrogen receptor signaling
Osteopontin-mediated events
PLK1 signaling events
PAR4-mediated thrombin signaling events
PAR1-mediated thrombin signaling events
Signaling events mediated by focal adhesion kinaseprlsignalingeventspathway:Signaling events mediated by PRL
RhoA signaling pathway
Noncanonical Wnt signaling pathway
EPHB forward signaling
Thromboxane A2 receptor signaling
amb2 Integrin signaling
Integrins in angiogenesis
EPHA forward signaling
Stabilization and expansion of the E-cadherin adherens junction
Signaling events mediated by VEGFR1 and VEGFR2
N-cadherin signaling events
Reactome EPHB-mediated forward signaling
EPHA-mediated growth cone collapse
G alpha (12/13) signalling events
Sema4D induced cell migration and growth-cone collapse
VEGFA-VEGFR2 Pathway
RHO GTPases Activate ROCKsR-HSA-111465:Apoptotic cleavage of cellular proteins
RHO GTPases Activate ROCKs
WikiPathways Signaling by HippoWP524:G13 Signaling Pathway
Regulation of Actin Cytoskeleton
Focal Adhesion
JAK/STAT
Spinal Cord Injury
Pathogenic Escherichia coli infection
Leptin signaling pathway
Semaphorin interactions
Integrin-mediated Cell Adhesion
GPCR downstream signaling
MicroRNAs in cardiomyocyte hypertrophy
Androgen receptor signaling pathwayWP524:G13 Signaling Pathway
EGF/EGFR Signaling Pathway
TGF beta Signaling Pathway
AGE/RAGE pathway
Regulation of Microtubule Cytoskeleton
Apoptotic execution phase
Androgen receptor signaling pathway
References
Ref 531084Tetrahydroisoquinoline derivatives as highly selective and potent Rho kinase inhibitors. J Med Chem. 2010 Aug 12;53(15):5727-37.
Ref 531084Tetrahydroisoquinoline derivatives as highly selective and potent Rho kinase inhibitors. J Med Chem. 2010 Aug 12;53(15):5727-37.